RGS12 and attention deficit-hyperactivity disorder: Methylphenidate responsiveness remains intact despite the loss of RGS12 function, suggesting that RGS12 functional variation in the human condition should not contraindicate methylphenidate use in mood-stabilized BD/ADHD comorbidity.